17.700
+0,00%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +20.0% | +53.9% | 3 / 3 | -8.2% | -24.39 pp | +0.10 pp | -112.1% | 0.78 | — | 11,5 | −8,2% | −3,4 | +8,5% | — | -18.45 | — |
| Pts | 4 | 12 | 12 | 0 | 0 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 17.700 (close price on 2026-10-19)EPS (TTM): −2.077,4
Financial charts
1.Revenue & growth
VND bn11,5Q2/26
1.Revenue & growth
VND bn11,5Q2/26
2.Profit & growth
VND bn-2,92Q2/26
3.Profit mix (Penman)
VND bn-33,3Q2/26
4.Margins & cost structure
%44.1%Q2/26
5.Returns & cash cycle
% · days-6.1%Q2/26
6.Earnings quality & cash
VND bn-20,7Q2/26
7.Asset structure
VND bn251Q2/26
8.Funding & debt health
VND bn · times251Q2/26
9.Revenue backlog
VND bn1,86Q2/26
10.Valuation
times · %-8,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-202Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26